We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pozen Inc. v. Par Pharmaceutical, Inc.

  1. August 8, 2011

    Pozen Wins Injunction On Generic Treximet

    A Texas federal judge ruled Friday that Par Pharmaceutical Cos. Inc. and two other drugmakers had infringed Pozen Inc.'s patents covering the migraine treatment Treximet and barred them from selling generic versions of the drug in the U.S. until certain patents expire.

  2. April 15, 2011

    Judge Blocks Par Pharma's Generic Treximet

    A Texas federal judge on Thursday barred Par Pharmaceutical Cos. Inc. from selling a generic version of Pozen Inc. migraine treatment Treximet in the U.S. until a patent infringement battle over the drug is resolved.